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Materials and Methods 
All synthetic procedures and experiments were performed in a nitrogen-atmosphere glove 
box or in sealed containers under a stream of nitrogen gas. All glassware was oven-dried for 24 
hours and kept under active vacuum for at least 8 hours prior to use. Dichloromethane (CH2Cl2), 
diethyl ether, tetrahydrofuran (THF), pentane and hexanes solvents were transferred from an 
oxygen- and water-free solvent system into sealed containers, degassed under active vacuum and 
stored over activated molecular sieves for 1 day prior to use. Deuterated benzene (Cambridge 
Isotope Laboratories) and toluene (used for catalytic experiments) were dried over 
Na/benzophenone, vacuum distilled and kept over activated molecular sieves prior to use. 
Deuterated CD2Cl2 was dried over CaH2, vacuum distilled and kept over activated molecular 
sieves prior to use. The syntheses of compounds 1,1 2,2 and 133 have been previously reported. 
AlMe3 and AlClMe2 (0.9 M in heptane) were purchased from Aldrich Chemical Co. M-MAO 3A 
was purchased from AkzoNobel as a 7% w/w Al solution in heptane. Anhydrous AlCl3 was 
purchased from Alfa Aesar as 99.998% grade. All other chemicals were purchased from Aldrich 
Chemical Co. and dried under active vacuum overnight prior to use. NMR spectra were recorded 
on a Varian Spectrometer. 1H and 13C NMR spectra were referenced to solvent resonances. 
31P{1H} NMR spectra were referenced to an 85% H3PO4 aqueous solution. All chemical shifts are 
reported in ppm.  
Ethylene Oligomerization  
Ethylene oligomerization experiments were carried out in a Fisher-Porter vessel equipped 
with a metal top regulator. The oven-dried Fisher-Porter vessel and the metal top regulator were 
kept under active vacuum overnight prior to setup in the glovebox. In a nitrogen-atmosphere 
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glove box, 8 μmol of CrCl3(THF)3 and 8 μmol of phosphine ligand were dissolved in 10 mL of 
toluene and added to the Fisher-Porter vessel (precatalyst concentration: 0.8 mM). The Fisher-
Porter vessel was then sealed and it was connected to an ethylene line outside the glove box. The 
ethylene feed was purified through a Matheson TriGas oxygen/moisture purifying column. The 
Fisher-Porter setup was purged with ethylene at 60 psi for 2 minutes and the pressure was then 
reduced to 20 psi. Under vigorous stirring, the MMAO solution was injected through a rubber 
septum and the pressure was increased to 60 psi. In all cases, the final reaction volume after 
injection of the activator or activator solution was 10 mL. The setup was kept at 25 ˚C for 1 hour, 
after which the reactor was depressurized and 10 mg of adamantane standard were added. The 
activator was quenched via the addition of 20 mL of 1M HCl(aq) and the organic portion was 
filtered through a pad of basic alumina. The amount of oligomers produced was determined via 
GC and the polymer was isolated via vacuum filtration over a fritted funnel and dried under 
active vacuum for 24 hours.  
X-Ray Crystallography 
Suitable crystals were mounted on a nylon loop using Paratone oil, then placed on a 
diffractometer under a nitrogen stream. X-ray intensity data were collected on a Bruker APEXII 
CCD area detector or a Bruker D8 VENTURE Kappa Duo PHOTON 100 CMOS detector 
employing Mo-Kα radiation (λ = 0.71073 Å) at a temperature of 100 K. All diffractometer 
manipulations, including data collection, integration and scaling were carried out using the 
Bruker APEX3 software. Frames were integrated using SAINT. The intensity data were 
corrected for Lorentz and polarization effects and for absorption using SADABS. Space groups 
were determined on the basis of systematic absences and intensity statistics using XPREP. Using 
Olex2, the structures were solved by direct methods using ShelXT and refined to convergence by 
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full-matrix least squares minimization using ShelXL. All non-hydrogen atoms were refined using 
anisotropic displacement parameters. Hydrogen atoms were placed in idealized positions and 
refined using a riding model. For complex 7b/7c, the substitutional disorder at C1 and Cl1 was 
modeled using the PART instruction. For complex 11, the positional disorder of the OAlCl3 
moiety was modeled using the PART instruction. For complex 12, the substitutional disorder of 
the [AlCl4]− and the [AlCl3Me]− anions was modeled using the PART instruction. 
Procedures 
[CrCl3(1)]2 (3). CrCl3(THF)3 (200 mg, 0.27 mmol) was suspended in CH2Cl2 (5 mL) and a 
solution of 1 (254 mg, 0.54 mmol) in CH2Cl2 (5 mL) was added in a dropwise fashion over 5 
minutes. The solution turned blue-green and was left to stir overnight. The solvent was then 
removed in vacuo yielding a blue-green solid. The residue was redissolved in CH2Cl2 (1.5 mL) 
and the product was obtained as purple crystals from vapor diffusion of pentane into the CH2Cl2 
solution. 1H NMR (400.16 MHz, 25˚C, C6D6): δ 13.79 (br s), 10.60 (br s), 7.46 (s), 6.93 (s), 6.02 
(br s), 4.20 (s), 3.55 (s), 1.96 (br s), 1.29 (br m), 0.82 (s), 0.25 (s), -0.88 (br s). 31P{1H} NMR 
(162.0 MHz, 25˚C, C6D6): silent. μeff = 5.4 μB. Anal. Calcd for C62H55Cl6Cr2N2P4: C, 58.70; H, 
4.37; N, 2.21. Found: C, 59.05; H, 5.56; N, 1.97. 
[CrCl3(2)]2 (4). CrCl3(THF)3 (200 mg, 0.27 mmol) was suspended in toluene (5 mL) and a 
solution of 2 (228 mg, 0.54 mmol) in toluene (5 mL) was added in a dropwise fashion over 5 
minutes. The solution turned blue and was left to stir overnight. The solvent was then removed in 
vacuo yielding a blue-purple solid. The residue was redissolved in CH2Cl2 (1.5 mL) and the 
product was obtained as blue-purple crystals from vapor diffusion of pentane into the CH2Cl2 
solution. 1H NMR (400.16 MHz, 25˚C, CD2Cl2): δ 15.35 (br s), 11.94 (br s), 10.59 (br s), 7.95-
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7.15 (m), 4.75-2.75 (m), 2.36 (s), 1.30-0.90 (m), 0.10 (s), -0.29 (br s). 31P{1H} NMR (162.0 
MHz, 25˚C, CD2Cl2): silent. μeff = 5.4 μB. Anal. Calcd for C54H55Cl6Cr2N2P4: C, 55.31; H, 4.73; 
N, 2.39. Found: C, 55.08; H, 4.82; N, 2.27. 
(p-tol)PNP-AlMe3 (5). Phosphine 1 (0.040 g, 0.084 mmol) and AlMe3 (0.055 g, 0.38 mmol) 
were mixed in 2 mL toluene. After 30 minutes, the colorless solution was transferred to a tared 
vial and reduced in vacuo to a sticky residue, redissolved in C6H6, and reduced to dryness in 
vacuo again. The remaining white solids were triturated with hexanes to yield the product as a 
white powder (0.045 g, 85% yield). 1H NMR (399.8 MHz, 23˚C, C6D6): 7.55 (m, 8H), 7.04 (m, 
12H), 6.60 (d, JH-H = 7.8 Hz, 2H), 6.51(d, JH-H = 7.8 Hz, 2H), 1.84 (s, 3H), -0.23 (s, 9H). ). 31P 
NMR (121.38 MHz, 25˚C, C6D6): 64.92 (s). 13C{1H} NMR (100.54 MHz, 25˚C, C6D6): δ 140.6 
(s), 136.7 (s), 135.4, 134.2 (t, JP-C = 10.0 Hz), 130.8, 130.4, 129.3, 128.53 (m), 20.7 (s), -7.2 (s). 
Anal. Calcd for C34H36AlNP2: C, 74.58; H, 6.63; N, 2.56. Found: C, 74.65; H, 6.64; N, 2.36. 
(p-tol)PPN-AlClMeX  (84 % 7a: X = Me; 16% 7b: X = Cl). Phosphine 1 (150 mg, 0.32 mmol) 
was dissolved in toluene (5 mL) and 0.70 mL of a 0.9 M AlClMe2 solution in heptane (2 equiv., 
0.64 mmol) were added in a dropwise fashion. After stirring overnight, the solvent was removed 
in vacuo and the white solids were redissolved in 2 mL of CH2Cl2. The product was obtained as 
colorless crystals via vapor diffusion of pentane into the CH2Cl2 solution (isolated yield 154 mg, 
86%). Quantitative assignment of Cl/Me substitution on Al for 7a versus 7b is based on the ratios 
of 1H NMR resonances at -1.13 and -1.29 ppm  and 31P resonances.  In the 13C spectrum, Al-CH3 
resonances for 7a and 7b overlap at -6.1 ppm, as do all other resonances in the 13C and 1H 
spectra. 1H NMR (400.16 MHz, 25˚C, CD2Cl2): δ 7.74 (m, 6 H), 7.60 (d, JH-H = 4 H), 7.31 (m, 2 
H), 7.08 (m, 4 H), 6.98 (m, 2 H), 6.65 (m, 6 H), 2.20 (s, 3 H), -1.13 (s, 0.5 H, AlCl2CH3), -1.29 
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(s, 5 H, AlCl(CH3)2). 31P{1H} NMR (162.0 MHz, 25˚C, CD2Cl2): δ 37.2 (d, JP-P = 293 Hz, 7a), 
39.5 (d, JP-P = 297 Hz, 7b), -10.3 (d, JP-P = 297 Hz, 7b), -10.6 (d, JP-P = 293 Hz, 7a). 13C{1H} 
NMR (100.54 MHz, 25˚C, CD2Cl2): δ 139.6 (s), 136.2 (s), 135.2, 135.1, 134.4, 133.9, 131.8, 
131.5, 130.7, 129.3, 129.2, 128.8, 127.7 (s), 127.0 (m), 20.9 (s), -6.1 (s). 
(i-Pr)PNP-Al2Cl3Me3 (8). Phosphine 2 (125 mg, 0.29 mmol) was dissolved in toluene (5 mL) 
and 0.98 mL of a 0.9 M AlClMe2 solution in heptane (3 equiv., 0.88 mmol) were added in a 
dropwise fashion. The solution was stirred at room temperature for 2 days and the solvent was 
removed in vacuo. The resulting white solid was redissolved in minimal CH2Cl2 and the product 
was obtained as clear crystals via vapor diffusion of pentane (isolated yield 172 mg, 92%). 1H 
NMR (300.08 MHz, 25˚C, C6D6): δ 7.57 (m, 8 H), 7.06 (m, 12 H), 3.74 (hept, JH-H = 6.2 Hz, 1 
H), 1.03 (d, JH-H = 6.6 Hz, 6 H), -0.21 (br m, 9 H). 31P{1H} NMR (121.48 MHz, 25˚C, C6D6): δ 
53.6 (br s). 13C{1H} NMR (100.54 MHz, 25˚C, C6D6): δ 137.7 (s), 133.1 (d, JC-P = 26.4 Hz), 
129.2 (s), 128.1 (d, JC-P = 7.5 Hz), 67.1 (s), 53.0 (s), 24.2 (s), 12.9 (s). Anal. Calcd for 
C30H36Al2Cl3NP2: C, 56.93; H, 5.73; N, 2.21. Found: C, 56.65; H, 5.78; N, 2.23. 
(i-Pr)PNP-H AlCl4 (10+[AlCl4]-). A solution of phosphine 2 (125 mg, 0.29 mmol) in CH2Cl2 (5 
mL) was added in a dropwise fashion to a AlCl3 (2 equiv., 78.1 mg, 0.59 mmol) suspension in 
toluene (2 mL). 1 equiv. of H2O (5.2 µL) were injected through a rubber septum and the mixture 
was stirred for 1 day. The volatiles were then removed and the resulting white solid was 
dissolved in minimal CH2Cl2. The product was obtained as colorless crystals via vapor diffusion 
of pentane into the CH2Cl2 solution (isolated yield 86 mg, 48%). 1H NMR (399.8 MHz, 25˚C, 
CD2Cl2): δ 8.47 (dd, JH-P = 14.3, 518 Hz, 1H), 7.88 (t, JH-H  =  7.0 Hz, 2H),  7.72-7.37  (m, 18 H), 
4.06 (m, 1 H), 1.39 (d, JH-H = 6.7 Hz, 6 H). 31P{1H} NMR (161.85 MHz, 25˚C, CD2Cl2): δ 52.3 
(d, JP-P = 11.7 Hz, 1 P), 21.4 (d, JP-P = 11.7 Hz, 1 P). 13C{1H} NMR (100.54 MHz, 25˚C, 
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CD2Cl2): δ 136.5 (s), 133.8 (d, JC-P = 12.7 Hz), 133.3 (dd, JC-P = 3.7, 15.3 Hz), 133.0 (d, JC-P = 
21.3 Hz), 131.7 (s), 130.9 (d, JC-P = 14.0 Hz), 130.0 (d, JC-P = 6.8 Hz), 118.7 (d, JC-P = 98.2 Hz), 
53.9 (s), 23.8 (s). HRMS Calc. for [M-AlCl4]+: 428.1697. Found: 428.1672. Anal. Calcd for 
C27H28AlCl4NP2: C, 54.30; H, 4.73; N, 2.35. Found: C, 53.45; H, 4.22; N, 2.30.	
PPO AlCl3 (11). A solution of phosphine 2 (125 mg, 0.29 mmol) in THF (5 mL) was added in a 
dropwise fashion to a AlCl3 (1 equiv., 39 mg, 0.29 mmol) in THF (2 mL). 1 equiv. of H2O (5.2 
µL) were injected through a rubber septum and the mixture was stirred for 2 days. The solvent 
was then removed in vacuo, the resulting white residue redissolved in CH2Cl2, and the crude 
product was precipitated out of solution via addition of pentane. From the resulting mixture, 
colorless crystals suitable for single crystal XRD were grown via vapor diffusion of pentane into 
a solution of the crude white powder in CH2Cl2. 
 [Cr2(p-tol-PNP)2Cl3Me2]AlCl4 (12). Complex 3 (50 mg, 0.039 mmol) was dissolved in toluene 
(10 mL) and the solution was frozen. As the solution was thawing, a 0.9 M solution of AlCl2Me 
in heptane (9 µL, 2 equiv., 0.078 mmol) were added. The solution turned green upon warming to 
room temperature and it was left to stir at room temperature for 2 hours. The solvent was then 
reduced to approximately 1 mL and the product was crystalized via vapor diffusion of pentane 
into the toluene solution (isolated yield 39 mg, 83%). The complex was observed to degrade 
room temperature, which was evidenced by a change in color and a deviation from the expected 
values in the elemental analysis.  1H NMR (400.16 MHz, 25˚C, C6D6): δ 11.79 (br m), 8.94 (br 
m), 7.90-5.80 (br m), 4.26 (br s), 3.54 (br m), 2.80-0.80 (br m), 0.00- –0.90 (br m). 31P{1H} 
NMR (162.0 MHz, 25˚C, C6D6): silent. µeff = 5.5 µB. Anal. Calcd for C64H60AlCl7Cr2N2P4: C, 
56.51; H, 4.45; N, 2.06. Found: C, 57.42; H, 4.78; N, 1.83. 
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Ph2PN(p-tol)Li·THF (14). (N-diphenylphosphino)-p-toluidine (300 mg, 1.03 mmol) was 
dissolved in 10 mL THF and the solution was cooled to -78 ˚C. A 2.5 M solution of n-BuLi in 
hexanes (0.41 mL, 2 equiv., 1.0 mmol) was added in a dropwise fashion via a rubber septum. 
After stirring for 30 minutes, the solution was allowed to warm up to room temperature and it 
was stirred for a further 60 minutes. The solvent was removed in vacuo and the resulting yellow 
sticky solid was triturated with pentane to give the product as a light yellow powder containing 1 
equiv. of THF as quantified by 1H NMR after pumping down the solids in vacuo for 4 hours (isolated 
yield: 362 mg, 98%). Colorless solid precipitate was observed to form from yellow MeCN solutions 
after about an hour, with only a slight shift in 1H and 31P resonances. 1H NMR (399.8 MHz, 25˚C, 
CD3CN): δ 7.52-7.41 (m, 4 H), 7.39-7.27 (m, 6 H), 6.91-6.78 (m, 4H), 3.65 (m, 4H), 2.17 (s, 3H), 1.80 
(m, 4H). 31P{1H} NMR (161.9 MHz, 25˚C, CD3CN): δ 30.8 (s). 13C{1H} NMR (125.7 MHz, 25˚C, 
CD3CN): δ 145.5 (d, J = 17.6 Hz), 141.4 (d, J = 12.2 Hz), 131.9 (d, J = 20.2 Hz), 130.5 (s), 129.9 (s), 
129.4 (d, J =6.4 Hz), 129.1 (s), 116.9 (d, J = 12.3 Hz), 68.3 (s), 26.2 (s), 20.4 (s).  Anal. Calcd for 
C23H25LiNOP: C, 74.79; H, 6.82; N, 3.79. Found: C, 74.04; H, 7.36; N, 3.61. 
Procedures for Reactions with PNP Ligands 
Representative Cyclam Quenching Procedure (Figure S8-S9): To a stirring solution of 1 (10 
mg) and CrCl3(THF)3 (8 mg, 1 equiv.)  in toluene (0.5 mL), a prepared solution of AlMe3 (0.5 
mL, 0.2 M in toluene, 4 equiv.) was added. The solution changed color from blue to green. After 
1 hour, the oily green suspension was used to dissolve cyclam (13 mg, 3 equiv.) and a brown 
solution was filtered from purple solids both immediately and after an addition 2 hours. The peak 
at 69 ppm corresponds to 1.  The peak at 29 ppm corresponds to Ph2PN(tol)H or Al-bound 
Ph2PN(tol) (Figure S19).  The peak at -27 ppm corresponds to Ph2PMe (Figure S20). 
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Representative Hydrolysis of MMAO Procedure (Figure S10-S11): To a stirring solution of 1 
(5.0 mg) in toluene (1 mL), MMAO-3A was added (0.06 mL, 10 equiv.) in the glovebox. The 
solution was added to a septum-capped NMR tube, and outside the glovebox, H2O (10 equiv.) 
was added via a microsyringe. A significant amount of solid precipitate formed in the NMR tube, 
and soluble species in the tube were monitored over time via 31P NMR. The peak at 69 ppm 
corresponds to 1. The peak at 29 ppm corresponds to Ph2P(O)Me, as opposed to Al-bound 
Ph2PN(tol). The sample was divided into two portions and separately spiked with an authentic 
sample of Ph2P(O)Me and Ph2PN(tol)Li· THF. Only in the former case did the resonance at 29 
ppm grow in to overlap perfectly with the additive.  The peak at -27 ppm corresponds to Ph2PMe 
(Figure S20). 
MeMgBr Reaction with 7 (Figure S15): To a stirring solution of solution of 1 (22 mg) in 
toluene (1 mL), AlMe2Cl (2 equiv.) was added. After 4 days, MeMgBr (1 equiv. in Et2O) was 
added, causing precipitate within seconds (magnesium salts). The soluble species were 
monitored over time via 31P NMR. The peak at 69 ppm corresponds to 1 (25%). The peak at 29 
ppm (<1%) is assigned to Al-bound or Mg-bound Ph2PN(tol), although some of these species 
may have precipitated out (Figure S19). The peak at -26 ppm corresponds to Ph2PMe (Figure 
S20) (7%). Unreacted 7 is present (63%), as well as an additional PPN species (32 ppm, -12 
ppm, 4%) that is not assigned. In a control experiment, addition of 2 equiv. AlMe2Cl to 12, 
followed by 1 equiv. MeMgBr, showed no degradation of the peak at 30 ppm (Al-bound PN 
species) over 20 hours. Furthermore, addition of MeMgBr to 1 in toluene, in a separate control 
experiment, showed no degradation of 1 after 16 hours. 
AlMe3 Reaction with 7 (Figure S15): To a stirring solution of solution of 1 (22 mg) in toluene 
(1 mL), AlMe2Cl (2 equiv.) was added. After 4 days, AlMe3 (50 equiv. in 0.5 mL toluene) was 
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added. The species in the homogeneous solution were monitored over time via 31P NMR. The 
product with a resonance at 24 ppm (53%) is not assigned, but is also reproduced by reacting 12 
with 2 AlMe2Cl followed by 50 AlMe3, suggesting intermediacy of a PN species in the reaction 
(Figure S19). The peak at -11 ppm is not assigned (6%). The peak at -24 ppm corresponds to Al-
bound Ph2PMe (Figure S21) (41%).4 
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NMR Characterization 
 
 
 
Figure S1. 1H, 31P{1H} and 13C{1H} NMR spectra of compound 5. 
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Figure S2. 1H, 31P{1H} and 13C{1H} NMR spectra of compound 7. 
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Figure S3. 1H, 31P{1H} and 13C{1H} NMR spectra of compound 8. 
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Figure S4. 1H, 31P{1H} and 13C{1H} NMR spectra of compound 10+[AlCl4]-. 
		 S15	
	
	
	
Figure S5. 1H, 31P{1H} and 13C{1H} NMR spectra of compound 14. 
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Figure S6. 31P{1H} NMR spectrum of HBArF4 + 1 (9+[BAr′4]-). 
 
 
Figure S7. 31P{1H} NMR spectrum of HBArF4 + 2 (10+[BAr′4]-) 
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Cr Extraction under Activation Conditions 
 
Figure S8. 31P{1H} NMR spectra  of cyclam extraction of 4 MMAO-3A + 1 + CrCl3(THF)3. 
 
Figure S9. 31P{1H} NMR spectra of cyclam extraction of 4 AlMe3 + 1 + CrCl3(THF)3. 
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PNP Reactivity with Hydrolyzed MMAO 
 
Figure S10. 31P{1H} NMR spectra of 1 + 10 MMAO-3A + 10 H2O. 
 
Figure S11. 31P{1H} NMR spectra of 1 + 10 MMAO-3A + 1 H2O. 
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Figure S12. 31P{1H} NMR spectra of 2 + 10 MMAO-3A + 10 H2O. 
PNP Reactivity with Chlorinated Alkyl Aluminum 
 
Figure S13. 31P{1H} NMR spectra of 1 + 2 AlMe2Cl. 
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Figure S14. 31P{1H} NMR spectra of 1 + 30 AlMe3. 
 
Figure S15. 31P{1H} NMR spectra of 7 (formed in situ) + MeMgBr. 
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Figure S16. 31P{1H} NMR spectra of 7 (formed in situ) + 50 AlMe3. 
 
Figure S17. 31P{1H} NMR spectra of 1 + 50 AlMe3, followed by 2 AlMe2Cl. 
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Figure S18. 31P{1H} NMR spectrum of 2 + 3 AlMe2Cl. 
  
Figure S19. 31P{1H} NMR spectra of 14 + 2 AlMe2Cl, followed by 50 AlMe3. 
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Figure S20. 31P{1H} NMR spectrum of Ph2PMe. 
 
Figure S21. 31P{1H} NMR spectrum of Ph2PMe + 30 MMAO. 
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Computational 
DFT calculations were performed using Gaussian 09 Revision C.01.5 The initial 
coordinates for the PNP and PPN moieties were extracted from the crystallographic coordinates 
from the solid-state structures of complexes 3 and 7. The P and N substituents were substituted 
for protons (Figure 7) or for methyl groups (Figure S22). The geometries were optimized 
without restraint using the 6-311+G(d,p) basis set and B3LYP-hybrid functional. The resulting 
geometries was confirmed as absolute energetic minima via frequency calculations that did not 
yield imaginary vibrations < -10 cm-1. The calculated electrostatic potentials were mapped, using 
GaussView, onto the 0.04 e-/Å3 electron density isosurface. Red regions indicate potential 
density below or equal to the minimum set limit and blue indicates potential density above or 
equal to the maximum set limit (see scale).  
In both theoretical models of the PPN and PNP isomers, either with H or methyl 
substituents, it was found that isomerization to PPN is accompanied by significant accumulation 
of electron density potential around the N atom. The truncated theoretical models of the PNP 
frameworks show that, in this isomer, the electron density is instead more localized around the 
ligating P atoms. 
 
Figure S22. Electrostatic potential mapped onto electron density isosurfaces (isovalue = 0.004 e-
/Å3) of model PMe2NMePMe2 (left) and isomerized PMe2PMe2NMe (right).  
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Crystallography 
Table S1. Crystal and Refinement Data for Complexes 3, 4, and 7.   
Compound 3 4 7b/7c 
CCDC 1471532 1471534 1471530 
Empirical formula C33H31Cl7CrNP2 C30H33Cl9CrNP2 C31.82H29.47AlCl2.17NP2 
Formula weight 803.68 840.56 591.96 
Temperature/K 100.02 100.01 99.99 
Crystal system triclinic triclinic triclinic 
Space group P-1 P-1 P-1 
a/Å 10.8962(7) 13.5833(11) 11.6158(8) 
b/Å 12.8113(15) 14.3977(14) 11.8725(10) 
c/Å 13.8238(17) 20.235(2) 12.0068(11) 
α/° 75.733(6) 94.594(5) 94.734(5) 
β/° 81.438(5) 92.147(5) 100.951(5) 
γ/° 73.265(5) 109.222(4) 110.634(5) 
Volume/Å3 1784.7(3) 3716.2(6) 1501.1(5) 
Z 2 4 2 
ρcalcg/cm3 1.496 1.502 1.310 
µ/mm-1 0.96 1.064 0.390 
F(000) 818 1708 615 
Crystal size/mm3 0.21 × 0.17 × 0.12 0.28 × 0.15 × 0.11 0.25 × 0.20 × 0.10 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 5.032 to 72.636 4.802 to 80 3.502 to 72.55 
Index ranges -18 ≤ h ≤ 18, -21 ≤ k ≤ 21, -23 ≤ l ≤ 23 
-24 ≤ h ≤ 24, -25 ≤ k ≤ 
25, -35 ≤ l ≤ 35 
-19 ≤ h ≤ 14, -19 ≤ k ≤ 
19, -19 ≤ l ≤ 18 
Reflections collected 112813 289169 24839 
Independent reflections 17281 [Rint = 0.0544, Rsigma = 0.0426] 
44225 [Rint = 0.0581, 
Rsigma = 0.0663] 
13728 [Rint = 0.0500, 
Rsigma = 0.1081] 
Data/restraints/parameters 17281/38/426 44225/0/837 12449/0/355 
Goodness-of-fit on F2 1.023 1.047 1.038 
Final R indexes [I>=2σ (I)] R1 = 0.0383, wR2 = 0.0770 
R1 = 0.0585, wR2 = 
0.1157 
R1 = 0.0708, wR2 = 
0.1878 
Final R indexes [all data] R1 = 0.0636, wR2 = 0.0852 
R1 = 0.1128, wR2 = 
0.1340 
R1 = 0.1405, wR2 = 
0.2275 
Largest diff. peak/hole / e Å-3 1.14/-1.25 1.11/-1.59 0.7/-1.63 
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Table S2. Crystal and Refinement Data for Complexes 8, 10+[AlCl4]-, and 11.  
 
Compound 8 10+[AlCl4]- 11 
CCDC 1471529 1471528 1471531 
Empirical formula C30H36Al2Cl3NP2 C27H28AlCl4NP2 C30H26AlCl3OP2 
Formula weight 632.85 597.22 597.78 
Temperature/K 100.02 99.99 100 
Crystal system triclinic orthorhombic monoclinic 
Space group P-1 P212121 Pc 
a/Å 10.5133(4) 10.2494(5) 9.3545(11) 
b/Å 12.7230(5) 15.7035(8) 9.3024(11) 
c/Å 13.7659(6) 17.8108(10) 17.270(2) 
α/° 64.1950(10) 90 90 
β/° 80.7120(10) 90 101.913(3) 
γ/° 80.8120(10) 90 90 
Volume/Å3 1627.68(11) 2866.7(3) 1470.5(3) 
Z 2 4 2 
ρcalcg/cm3 1.291 1.384 1.35 
µ/mm-1 0.455 0.573 0.473 
F(000) 660 1232 616 
Crystal size/mm3 0.26 × 0.22 × 0.15 0.23 × 0.16 × 0.15 0.48 × 0.22 × 0.16 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.878 to 61.076 3.458 to 61.082 4.378 to 75.408 
Index ranges -15 ≤ h ≤ 15, -18 ≤ k ≤ 18, -19 ≤ l ≤ 19 
-14 ≤ h ≤ 14, -22 ≤ k ≤ 
19, -25 ≤ l ≤ 25 
-13 ≤ h ≤ 13, -13 ≤ k ≤ 
13, -24 ≤ l ≤ 24 
Reflections collected 73966 59918 61923 
Independent reflections 9931 [Rint = 0.0345, Rsigma = 0.0222] 
8770 [Rint = 0.0432, Rsigma 
= 0.0278] 
9057 [Rint = 0.0376, 
Rsigma = 0.0243] 
Data/restraints/parameters 9931/0/348 8770/0/322 9057/2/362 
Goodness-of-fit on F2 1.069 1.063 1.060 
Final R indexes [I>=2σ (I)] R1 = 0.0394, wR2 = 0.1096 
R1 = 0.0237, wR2 = 
0.0549 
R1 = 0.0304, wR2 = 
0.0793 
Final R indexes [all data] R1 = 0.0485, wR2 = 0.1145 
R1 = 0.0265, wR2 = 
0.0582 
R1 = 0.0364, wR2 = 
0.0823 
Largest diff. peak/hole / e Å-3 0.52/-1.48 0.43/-0.24 0.43/-0.27 
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Table S3. Crystal and Refinement Data for Complex 12. 
 
Compound 12 
CCDC 1471533 
Empirical formula C78.76H78.28AlCl6.24Cr2N2P4 
Formula weight 1528.95 
Temperature/K 100 
Crystal system triclinic 
Space group P-1 
a/Å 14.6582(5) 
b/Å 22.7883(8) 
c/Å 24.5404(9) 
α/° 68.6350(10) 
β/° 88.7120(10) 
γ/° 88.3820(10) 
Volume/Å3 7630.3(5) 
Z 4 
ρcalcg/cm3 1.331 
µ/mm-1 0.642 
F(000) 3168 
Crystal size/mm3 0.21 × 0.20 × 0.07 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.48 to 60.998 
Index ranges -20 ≤ h ≤ 20, -32 ≤ k ≤ 32, -35 ≤ l ≤ 35 
Reflections collected 215976 
Independent reflections 46404 [Rint = 0.0545, Rsigma = 0.0572] 
Data/restraints/parameters 46404/2754/1727 
Goodness-of-fit on F2 1.074 
Final R indexes [I>=2σ (I)] R1 = 0.0573, wR2 = 0.1261 
Final R indexes [all data] R1 = 0.0948, wR2 = 0.1385 
Largest diff. peak/hole / e Å-3 1.42/-1.27 
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